Literature DB >> 5935016

Activation of systemic lupus erythematosus by drugs.

S L Lee, I Rivero, M Siegel.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5935016

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  9 in total

1.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

2.  Procainamide-induced systemic lupus erythematosus.

Authors:  P J Sheldon; W R Williams
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

3.  Procainamide-induced systemic lupus erythematosus.

Authors:  C J Atkins; E B Hamilton
Journal:  Proc R Soc Med       Date:  1969-02

4.  Induction by isoniazid and hydrallazine of antinuclear factors in mice.

Authors:  A Cannat; M Seligmann
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

5.  Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

Authors:  D Alarcón-Segovia; E Fishbein; V M Betancourt
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

6.  Lupus-like syndrome induced by procainamide.

Authors:  D G McDevitt; J F Glascow
Journal:  Br Med J       Date:  1967-09-23

Review 7.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other gram-negative infections.

Authors:  D A Isenberg; P Maddison; G Swana; R P Skinner; M Swana; M Jones; I Addison; C Dudeney; S Shall; A el Roiey
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

Review 9.  Antinuclear antibodies and cardiovascular drugs.

Authors:  J D Wilson
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.